Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Aldeyra, Appili, Arch, Ascentage, Beigene, Beyondspring, Canbridge, Gan & Lee, Gannex, Junshi, Kiadis, Mateon, Reven, SK, Vaxart, Zai.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Anges, Anheart, ABL, Arctoris, Ascletis, Asia Green, Astrazeneca, Atomwise, Auris Medical, Axon Neuroscience, Berg, Biocomo, Biontech, Brickell, Caladrius, Canbridge, Cheplapharm Arzneimittel, China SXT, Clinuvel, Cmab, Cymerus, Daiichi Sankyo, Destiny, Exmceuticals, Gain, Galmed, GC Pharma, Gigagen, Ginkgo Bioworks, Glaxosmithkline, Glycot, Harbour Biomed, Hifibio, Hualan Genetic Engineering, Ibio, Icanomab, Immunomic, Inovio, Inveniai, Johnson & Johnson, Know Bio, Laekna Therapeutics Shanghai, Mab Discovery, Medicinova, Medigen, Moderna, Molecular Partners, Moleculin, Monopar, Northstar Medical Radioisotopes, Novavax, Orexo, Otsuka, Pathway Rx, Pfizer, Presage, Prism Biolab, Recce, Redhill, Regenerx, Rockwell Medical, Sanofi, Sporegen, Starpharma, Sumitomo Dainippon, Sun, Syntekabio, Takeda, Totient, Valneva, Vaxart, Vaxess, Vaxil.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Oncoimmune.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Opthea.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aerie, Amryt, Apellis, Ardelyx, Astrazeneca, BMS, Boehringer, Epimab, Equillium, Gensight, Gilead, Kiniksa, Lilly, Mateon, Matinas, Novartis, Plus, Takeda, Zynerba.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adicet, Alimera, Anelixis, Applied Stemcell, Axovant, Bayer, Biontech, BMS, Bostongene, C3.ai, Cell and Gene Therapy Catapult, Cellinta, Combigene, Corino, Cullinan, Cue, ERS Genomics, Exelixis, Fosun, Genexine, Humanigen, Iconic, Innovation Pharma, Kiadis, Mabion, Medis, Melior, Mindset, Miragen, Momenta, Mylan, Novavax, Novus, Obsidian, Oligomerix, Pfizer, Protokinetix, Restorbio, Serum Institute of India, Soligenix, Systems Oncology, Teva, Tonix, Vaxine.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adocia, Aerpio, Arbutus, Atossa, Atyr, Axsome, Clinuvel, Codiak, Curasen, Curevo, Galecto, Kyorin, Marinus, Opko, Teva, TFF, Tyme.

Biopharmas raising money in public or private financings, including: 89bio, Ansa, Aziyo, Hexagon, Humanigen, Imcheck, Novaremed, Proteodesign, Sunshine.

New hires and promotions in the biopharma industry, including: Adverum, Aravive, Atea, Aviceda, Haima, Immatics, Kronos, Matinas, Miragen, Nextcure, Partner, Rhythm, Rockwell, Veracyte, Voyager, Vtv, Tizona, Ziopharm.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, B-Temia, Fitbit, Micron Medical.